Exosens SAS (EXENS)
Euronext
58.40
+3.45 (+6.28%)
Closed
Oct 9, 2026
Day's Range
54.4058.60
52 wk Range
40.0074.00
Financial Statements - EXENS - Exosens SAS
Revenue
383.40M▼ 18.1%
Net Income
30.70M▼ 28.1%Net Margin 8.0%
EBITDA
120.10M▼ 15.5%
Free Cash Flow
107.40M▲ 8.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 383.40M | 468.20M | 291.81M | 200.75M | 166.16M | 149.85M |
| Cost of Goods | 161.10M | 190.70M | 80.30M | 86.79M | 66.13M | 58.02M |
| Gross Profit | 222.30M | 277.50M | 211.51M | 113.95M | 100.03M | 91.83M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 80.60M | 102.20M | 54.62M | 32.95M | 32.36M | 30.63M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 45.80M | 88.20M | 20.24M | 17.10M | -150.26M | -13.23M |
| Income Tax | 11.60M | 18M | 1.83M | 5.89M | -1.29M | 2.59M |
| Net Income | 30.70M | 42.70M | 18.40M | 11.21M | -148.96M | -15.82M |
| EPS Basic | 0.605649 | 0.841141 | 0.242042 | 0.368969 | -4.902205 | -0.520875 |
| EPS Diluted | 0.605649 | 0.841141 | 0.242042 | 0.368969 | -4.902205 | -0.520875 |
| Basic Shares Outstanding | 50.68M | 50.76M | 30.38M | 30.38M | 30.38M | 30.38M |
| Diluted Shares Outstanding | 50.68M | 50.76M | 30.38M | 30.38M | 30.38M | 30.38M |
| Ebit | 80.60M | 102.20M | 47.15M | 32.25M | -112.66M | 28.64M |
| Ebitda | 120.10M | 142.10M | 79.93M | 51.91M | -98.14M | 34.10M |
| Net Income Continuous Operations | 70.20M | 34.10M | 18.40M | 11.21M | -148.96M | -15.82M |
| Minority Interests | - | - | - | - | 0 | 0 |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
